Completed NA INTERVENTIONAL 2-arm NCT04965844

Closed-loop Oxygen Control for High Flow Nasal Therapy (HILOOP)

Safety and Efficacy of a Closed-loop Oxygen Control for High Flow Nasal Therapy in ICU Patients: a Randomized Cross-over Study (The HILOOP Study)

Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Conditions Acute Respiratory Failure High Flow Nasal Cannula Hyperoxemia Hypoxemia Oxygen Therapy Respiratory Insufficiency

Interventions No intervention Oxygen close-loop

Updated 6 times since 2021 Last updated: Nov 26, 2021 Started: Apr 27, 2021 Primary completion: Aug 10, 2021 Completion: Aug 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Respiratory Failure and High Flow Nasal Cannula, this trial is completed. The trial is conducted by Hospital Universitari Vall d'Hebron Research Institute and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA
Nov 2021 — Jan 2022 [monthly]

Completed NA
Oct 2021 — Nov 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Sep 2021 — Oct 2021 [monthly]

Recruiting NA

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitari Vall d'Hebron Research Institute

Data source: Hospital Universitari Vall d'Hebron Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain